New PET probe aims to spot hidden cancer spread

NCT ID NCT07331532

Recruiting now Diagnosis Sponsor: Peking University First Hospital Source: ClinicalTrials.gov ↗

First seen Jan 12, 2026 · Last updated May 24, 2026 · Updated 21 times

Summary

This study tests a new imaging probe called 68Ga-PFA2 for PET scans to see if it can better detect cancer that has spread in people with lung cancer. The probe targets a protein called Annexin A2, which is often found in high levels on many cancer cells. Researchers will compare this new method to the standard PET scan to see if it is more accurate. About 10 adults with confirmed lung cancer will take part.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EXPLORING THE DIAGNOSTIC POTENTIAL OF 68GA-PFA2 PET IMAGING IN ANNEXIN A2-POSITIVE TUMORS, INCLUDING BREAST CANCER, LUNG CANCER, AND PANCREATIC CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Peking university first hospital nuclear medicine
RECRUITING

Beijing, Beijing Municipality, China

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact

Conditions

Explore the condition pages connected to this study.

BREAST NEOPLASMS、LUNG NEOPLASMS、PANCREATIC NEOPLASMS BREAST NEOPLASMS、LUNG NEOPLASMS、PANCREATIC NEOPLASMS EXPLORING THE DIAGNOSTIC POTENTIAL OF 68GA-PFA2 PET IMAGING IN ANNEXIN A2-POSITIVE TUMORS, INCLUDING BREAST CANCER, LUNG CANCER, AND PANCREATIC CANCER